A "Duty" to Continue Selling Medicines

Area of Science:

• Pharmaceutical Law
• Medical Ethics
• Health Policy

Background:

• Prescription drug shortages are a recurring problem, sometimes impacting life-saving medications.
• Negligent manufacturing decisions can exacerbate these critical drug supply issues.
• Seriously ill patients have pursued legal action to compel drug manufacturers to maintain supply.

Purpose of the Study:

• To analyze recent court cases challenging pharmaceutical supply interruptions.
• To explore existing legal frameworks for imposing a duty on manufacturers to continue selling drugs.
• To evaluate the feasibility and implications of judicially creating such a duty.

Main Methods:

• Review of two specific court cases (Utah and Florida) concerning compelled medicine access.
• Analysis of prior case law related to experimental drug access.
• Survey of constitutional, statutory, regulatory, and case law for potential duties.
• Examination of policy considerations for and against a mandated supply duty.

Main Results:

• Both recent court cases failed to establish a legal duty for manufacturers to perpetually supply medicines.
• Existing legal theories are unlikely to support a credible claim for compelled drug sales.
• Judicial invention of a continuous supply duty is deemed unwise due to competing interests.

Conclusions:

• Current legal avenues are insufficient to compel drug manufacturers to maintain perpetual supply.
• A legislative amendment is proposed to balance manufacturer interests with patient access to critical medicines.
• The study highlights the need for policy solutions to address persistent drug shortages.